XNAS · Laboratory Analytical Instruments · S&P 500
$27.71
+$1.19 (+4.49%) today
Open $26.52 High $27.73 Low $26.04 Vol 86K Avg $27.14
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| SINT | SiNtx Technologies, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| BAX | Baxter International Inc. | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| BSX | Boston Scientific Corp. | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| TNON | Tenon Medical, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| IART | Integra LifeSciences Holdings | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| SGP | SpyGlass Pharma, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| NVNO | enVVeno Medical Corporation Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| NEGG | Newegg Commerce, Inc. Common Shares | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| MMM | 3M Company | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| XTNT | Xtant Medical Holdings, Inc. | XASE | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
52-week price range
Price is 62.4% above its 52-week low and 14.6% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.